How well does Lynparza(Olaparib) work?

Clinical trials demonstrated significant improvement in progression-free survival across multiple cancer types.

Treatment Outcomes

Lynparza showed notable efficacy in maintaining response after platinum-based chemotherapy in ovarian cancer, reducing recurrence risk in early breast cancer, and delaying disease progression in pancreatic and prostate cancers. Benefits were particularly evident in patients with BRCA or HRR gene mutations.

Olaparib(Lynparza)
LYNPARZA is a PARP inhibitor used for maintenance or treatment of certain advanced cancers with specific genetic mutations, including ovarian, breast, pancreatic, and prostate...
RELATED ARTICLES
/ 0
0 in total
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
Mailbox:Info@Lucius.La
Welcome To Consult
Ucius Pharmaceuticals (Lao) Co.,Ltd All Rights Reserved